Check(point) Yourself Before You Wreck Yourself: Challenges with Checkpoint Inhibitor Immunotherapy

Rochester, NY US
December 4, 2019

This activity will provide a detailed overview of some complications associated with checkpoint inhibitor immunotherapy, with a focus on re-challenging after immune-related adverse events, and hyperprogressive disease. After participating in this activity, pharmacists should have a greater understanding of the risks associated with these medications and appropriate clinical considerations.

Target Audience

  • Pharmacists

Learning Objectives

Pharmacist learning objectives

  1. Recognize the mechanisms of action and common indications of immune checkpoint inhibitors
  2. Identify the major immune-mediated toxicities associated with checkpoint inhibitors
  3. Describe the safety and efficacy of re-challenging with checkpoint inhibitors after experiencing immune-related toxicity
  4. Discuss the importance and clinical considerations of hyperprogression associated with immune checkpoint inhibitors
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
12/04/2019 - 7:00am
Event ends: 
12/04/2019 - 8:00am
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members and the presenter have nothing to disclose
Planning committee members
Linda Thomas, PharmD
University of Rochester Medical Center
Frank Lattuca, PharmD
PGY-2 Oncology Pharmacy Resident
University of Rochester Medical Center
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLE
Clinical Pharmacy Director
Frank Lattuca, PharmD
PGY-2 Oncology Pharmacy Resident
University of Rochester Medical Center



Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-233-L01-P
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance


Please login or register to take this course.